CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


less-frequency hemodialysisWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)


Name (Synonyms) Correlation

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D007676 Kidney Failure, Chronic NIH 0.41

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Reduced Frequency Hemodialysis in Prevalent Patients Due to the Coronavirus Disease

Facing the unusual situation imposed by the coronavirus disease, the aim of this study is to evaluate the risk and effects of less frequent hemodialysis on prevalent patients

NCT04374058 End Stage Renal Disease Other: less-frequency hemodialysis
MeSH:Kidney Failure, Chronic

Primary Outcomes

Description: Time to all-cause and cardiovascular death

Measure: Mortality

Time: From date of beginning of the study until the date of death assessed up to 52 weeks

Secondary Outcomes

Description: Time variation of the biological parameters mentioned in the title. Repeated measurements of laboratory variables will be averaged into patient quarterly means to minimize measurement variability.

Measure: Anemia, Nutrition, Adequation of dialysis, total ultrafiltration, ultrafiltration rate,

Time: From date of beginning of the study assessed up to 52 weeks

Description: Time to first hospitalization of any cause

Measure: Hospitalization

Time: From date of beginning of the study until the date of first hospitalization assessed up to 52 weeks

Description: Time to first endovascular or quirurgical intervention of the vascular access utilized at the start of the study

Measure: Vascular Access

Time: From date of beginning of the study until the date of first intervention assessed up to 52 weeks


No related HPO nodes (Using clinical trials)